Fieldview Capital Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,878
Closed -$225K – 615
2026
Q2
$225K Buy
+2,878
New +$196K 0.06% 462
2025
Q4
– Sell
-10,705
Closed -$785K – 551
2025
Q3
$785K Buy
+10,705
New +$711K 0.13% 209

Other funds holding HALO

Fieldview Capital Management's HALO Position: Q3 2026 in Review

Fieldview Capital Management sold out of Halozyme (HALO) in Q3 2026, closing a stake of 2,878 shares — an estimated $225K sold.

Fieldview Capital Management first reported a position in HALO in Q3 2025 and held it in 2 quarters. The position peaked at $785K in Q3 2025. 768 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Fieldview Capital Management reported no remaining Halozyme position as of Q3 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 2,878 Halozyme shares in Q3 2026, an estimated $225K.
  • Fieldview Capital Management first reported a position in Halozyme in Q3 2025 and held it in 2 quarters.
  • Fieldview Capital Management's Halozyme position peaked at $785K in Q3 2025.
  • 768 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Fieldview Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.